| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| d-4418 | phosphodiesterase 4a | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma T-Cell Cutaneous[MeSHID:D016410] |
NA | discontinued in phase 1 | unknown |
| d-4418 | phosphodiesterase 4b | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma T-Cell Cutaneous[MeSHID:D016410] |
NA | discontinued in phase 1 | unknown |
| d-4418 | phosphodiesterase 4d | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma T-Cell Cutaneous[MeSHID:D016410] |
NA | discontinued in phase 1 | unknown |
| click here to return to the previous page | ||||||||